US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 474 actively recruiting studies with Ohio sites out of 474 registered in total. The busiest research areas in Ohio are Acute Myeloid Leukemia, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, Ohio State University, The Cleveland Clinic. By stage, Ohio trials break down as Phase 1 (73), Phase 2 (129), Phase 3 (135), Phase 4 (17).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
474
Recruiting Now
474
← Back to US Map
Top Conditions in Ohio
Acute Myeloid Leukemia (8)Endometrial Cancer (7)Advanced Solid Tumor (6)Heart Failure (6)Multiple Myeloma (5)Ovarian Cancer (5)Stroke (5)Breast Cancer (5)Solid Tumor (4)Prostate Cancer (4)Autism Spectrum Disorder (4)Chronic Lymphocytic Leukemia (4)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 474 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 474. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT06189755 N/A
Recruiting
MicroRNAs as Biomarkers for Obstructive Sleep Apnea
Condition
Obstructive Sleep Apnea
Enrollment
500 pts
Location
United States, Iceland
Sponsor
University of Pennsylvania
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06773910 Phase 2
Recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lu...
Condition
Limited Stage Small Cell Lung Cancer
Enrollment
250 pts
Location
United States
Sponsor
SCRI Development Innovations,
View Trial →
NCT07379684 Phase 1
Recruiting
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic W...
Condition
Surgical Wound Infection
Enrollment
44 pts
Location
United States
Sponsor
Macro Biologics, Inc.
View Trial →
NCT07049055 Phase 1, Phase 2
Recruiting
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-pacli...
Condition
Pancreatic Cancer, Metastatic
Enrollment
144 pts
Location
United States
Sponsor
Engeneic Pty Limited
View Trial →
NCT07220876 N/A
Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refract...
Condition
Open Angle Glaucoma (OAG)
Enrollment
165 pts
Location
United States, South Africa
Sponsor
Avisi Technologies Inc.
View Trial →
NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,750 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT07060261 N/A
Recruiting
Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squ...
Condition
Human Papilloma Virus Related Carcinoma
Enrollment
30 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT06527157 N/A
Recruiting
Investigations of Reproductive Cancers in Women
Condition
Uterine Cancer
Enrollment
4,500 pts
Location
United States
Sponsor
PinkDx, Inc.
View Trial →
NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
View Trial →
NCT06906341 Phase 2
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With G...
Condition
Ovarian Cancer
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Corcept Therapeutics
View Trial →
NCT06034405 N/A
Recruiting
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin ...
Condition
Lumbar Spinal Stenosis
Enrollment
1,663 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT06885281 Phase 1, Phase 2
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
Condition
Solid Tumors
Enrollment
166 pts
Location
United States, China
Sponsor
Zai Lab (Shanghai) Co., Ltd.
View Trial →
NCT05103683 Phase 1
Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Condition
Advanced Solid Tumor
Enrollment
90 pts
Location
United States, South Korea
Sponsor
TORL Biotherapeutics, LLC
View Trial →
NCT06187402 Phase 1, Phase 2
Recruiting
A Study of LM-24C5 For Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
49 pts
Location
United States
Sponsor
LaNova Medicines Limited
View Trial →
NCT06917586 N/A
Recruiting
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
Condition
Valve Disease, Heart
Enrollment
300 pts
Location
United States
Sponsor
Michael Moront
View Trial →
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT02235857 N/A
Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmen...
Condition
Focal Segmental Glomerulosclerosis
Enrollment
35 pts
Location
United States
Sponsor
Kaneka Medical America LLC
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT01954992 Phase 3
Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Condition
Metastatic Pancreatic Adenocarcinoma
Enrollment
480 pts
Location
United States
Sponsor
Eleison Pharmaceuticals LLC.
View Trial →
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT07207395 Phase 2
Recruiting
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizuma...
Condition
Lung Cancer (NSCLC)
Enrollment
30 pts
Location
United States
Sponsor
The Christ Hospital
View Trial →
Page 1 of 19 — 474 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology